Aesthetic manufacturer VIVACY Laboratories hosted an event at its headquarters to mark the debut of its new calcium hydroxylapatite (CaHA) injectable, Novuma.
Delegates attended an afternoon of networking alongside faculty members including aesthetic practitioners Dr Zunaid Alli, Dr Cemal Kavasogullari and Dr Thuha Jabbar, among others. During the event, Dr Alli carried out a live demonstration of Novuma outlining the protocol, injection technique and product volume used as part of the treatment.
Katie Hughes-Dawkins, sales director at VIVACY Laboratories, commented, “As our next-generation CaHA technology, Novuma has been developed to meet immediate aesthetic improvement and long-term tissue regeneration. We are so proud to bring this innovative solution to practitioners and further strengthen our premium VIVACY Laboratories portfolio of regenerative medicine and hyaluronic acid solutions.”